Literature DB >> 3039629

Large cell carcinoma of the lung.

R Yesner.   

Abstract

The diagnosis of large cell carcinoma of the lung on the basis of hematoxylin and eosin (H & E) stains represents a heterogeneous group, both endodermally and non-endodermally derived, totalling about 16% of lung cancers. By the use of special stains, such as Kreyberg and Grimelius stains, this percentage can be sharply reduced, leaving a core group of about 10%, including giant cell and clear cell variants. This core group may show a variety of ultramicroscopic organelles that are insufficiently developed to alter the light microscopic characteristics on which the diagnosis depends. In a study of 1000 slides, large cell carcinoma constituted 6% of the squamous cell carcinoma slides and 21% of the adenocarcinoma slides, which was reduced to 3% by mucin stains. Giant cells predominated in 5% and clear cells in 10% of large cell carcinoma slides. Large cells also occurred in 12% of small cell carcinoma slides.

Entities:  

Mesh:

Year:  1985        PMID: 3039629

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  3 in total

1.  Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study.

Authors:  Erik Thunnissen; Mary Beth Beasley; Alain C Borczuk; Elisabeth Brambilla; Lucian R Chirieac; Sanja Dacic; Douglas Flieder; Adi Gazdar; Kim Geisinger; Philip Hasleton; Yuichi Ishikawa; Keith M Kerr; Sylvie Lantejoul; Yoshiro Matsuno; Yuko Minami; Andre L Moreira; Noriko Motoi; Andrew G Nicholson; Masayuki Noguchi; Daisuke Nonaka; Giuseppe Pelosi; Iver Petersen; Natasha Rekhtman; Victor Roggli; William D Travis; Ming S Tsao; Ignacio Wistuba; Haodong Xu; Yasushi Yatabe; Maureen Zakowski; Birgit Witte; Dirk Joop Kuik
Journal:  Mod Pathol       Date:  2012-07-20       Impact factor: 7.842

2.  Correlation of immunohistochemical staining p63 and TTF-1 with EGFR and K-ras mutational spectrum and diagnostic reproducibility in non small cell lung carcinoma.

Authors:  Erik Thunnissen; Evan Boers; Daniëlle A M Heideman; Katrien Grünberg; Dirk J Kuik; Arnold Noorduin; Matthijs van Oosterhout; Divera Pronk; Cees Seldenrijk; Hannie Sietsma; Egbert F Smit; Robertjan van Suylen; Jan von der Thusen; Bart Vrugt; Anne Wiersma; Birgit I Witte; Michael den Bakker
Journal:  Virchows Arch       Date:  2012-10-12       Impact factor: 4.064

3.  Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma.

Authors:  Natasha Rekhtman; Laura J Tafe; Jamie E Chaft; Lu Wang; Maria E Arcila; Agnes Colanta; Andre L Moreira; Maureen F Zakowski; William D Travis; Camelia S Sima; Mark G Kris; Marc Ladanyi
Journal:  Mod Pathol       Date:  2012-11-30       Impact factor: 7.842

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.